M42 and Hikma sign strategic MOU to enhance preventive and predictive cancer care in the UAE
London - M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), announced the signing of a strategic memorandum of understanding (MOU), to accelerate the implementation of more precise, preventive and predictive cancer care programmes, utilising cutting-edge genomics screening technology.
Posted by Hicham ALAOUI RIZQ on 2025, Feb 01
Introduction
London - M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), announced the signing of a strategic memorandum of understanding (MOU), to accelerate the implementation of more precise, preventive and predictive cancer care programmes, utilising cutting-edge genomics screening technology.
Article Link
Read more: M42 and Hikma sign strategic MOU to enhance preventive and predictive cancer care in the UAE